Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-08-10 Moxham Christopher Chief Scientific Officer Exercise or conversion +20,714 $7.84 $162K 20,714
2021-08-10 Moxham Christopher Chief Scientific Officer Sale −20,714 $17.00 $352K 0
2021-08-10 Moxham Christopher Chief Scientific Officer Exercise or conversion +31,071 $7.84 $244K 31,071
2021-08-10 Moxham Christopher Chief Scientific Officer Sale −31,071 $18.00 $559K 0
2021-08-10 Moxham Christopher Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −20,714 103,572
2021-08-10 Moxham Christopher Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −31,071 72,501
2021-02-08 Moxham Christopher Chief Scientific Officer Grant or award · Stock Option (right to buy) +100,000 100,000

Page 1 of 1 · 7 trades